David Arcia-Anaya

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Cell Proliferation

Top Venues

Nature reviews. Immunology

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

David Arcia-Anaya, Tim Elliott
STAT5A antagonizes TOX in CD8 + T cell exhaustion. Nature reviews. Immunology 23 (2) (2023)
Gessa Sugiyarto, Doreen Lau, Samuel Luke Hill, David Arcia-Anaya, Denise S M Boulanger, Eileen E Parkes, Edward James, Tim Elliott
Reactivation of low avidity tumor-specific CD8 + T cells associates with immunotherapeutic efficacy of anti-PD-1. Journal for immunotherapy of cancer 11 (8) (2023)
David Arcia-Anaya, Tim Elliott
STAT5A antagonizes TOX in CD8 + T cell exhaustion. Nature reviews. Immunology (2023)
David Arcia-Anaya, Tim Elliott
STAT5A antagonizes TOX in CD8 + T cell exhaustion. Nature reviews. Immunology 23 (2) (2023)